NCT01304485View on ClinicalTrials.gov

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Prostate Cancer
Interventions
DRUG

Sodium Acetate C11

PET Imaging with Sodium Acetate C11

Trial Locations (1)

85040

Phoenix Molecular Imaging, Phoenix

Sponsors
All Listed Sponsors
lead

Phoenix Molecular Imaging

OTHER

NCT01304485 - PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | Biotech Hunter | Biotech Hunter